Allan O Langlands

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi Modelling interrupted time series to evaluate prevention and control of infection in healthcare
    V Gebski
    Division of Healthcare Quality Promotion, Centres for Disease Control and Prevention, Atlanta, GA, USA
    Epidemiol Infect 140:2131-41. 2012
  2. ncbi Clinical trial design in oncology: assessment of outcomes
    Val Gebski
    NHMRC Clinical Trials Centre, University of Sydney, Australia
    Lancet Oncol 5:761-3. 2004
  3. ncbi Statistical methods in clinical trials
    Val J Gebski
    NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450
    Med J Aust 178:182-4. 2003
  4. ncbi Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective
    Val Gebski
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia
    J Natl Cancer Inst 98:26-38. 2006
  5. ncbi Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
    Val Gebski
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
    Lancet Oncol 8:226-34. 2007
  6. ncbi Radiotherapy in the treatment of breast cancer: a personal retrospective
    Allan O Langlands
    Breast 15:698-703. 2006
  7. ncbi Uterine papillary serous carcinoma: patterns of failure and survival
    Wei Wang
    Department of Radiation Oncology, Westmead Hospital, Sydney, New South Wales, Australia
    Aust N Z J Obstet Gynaecol 49:419-25. 2009
  8. ncbi Factorial designs: a graphical aid for choosing study designs accounting for interaction
    Karen Byth
    NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia
    Clin Trials 1:315-25. 2004
  9. ncbi Dynamic balancing randomization in controlled clinical trials
    Stephane Heritier
    National Health and Medical Research Council NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
    Stat Med 24:3729-41. 2005
  10. ncbi Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects?
    Anthony C Keech
    NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia
    Med J Aust 177:445-7. 2002

Collaborators

Detail Information

Publications40

  1. ncbi Modelling interrupted time series to evaluate prevention and control of infection in healthcare
    V Gebski
    Division of Healthcare Quality Promotion, Centres for Disease Control and Prevention, Atlanta, GA, USA
    Epidemiol Infect 140:2131-41. 2012
    ..Both approaches yielded consistent results. Where feasible, a model adjusting for the unit effect should be fitted, or if there is heterogeneity, an analysis incorporating a random effect for units may be appropriate...
  2. ncbi Clinical trial design in oncology: assessment of outcomes
    Val Gebski
    NHMRC Clinical Trials Centre, University of Sydney, Australia
    Lancet Oncol 5:761-3. 2004
  3. ncbi Statistical methods in clinical trials
    Val J Gebski
    NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450
    Med J Aust 178:182-4. 2003
  4. ncbi Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective
    Val Gebski
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia
    J Natl Cancer Inst 98:26-38. 2006
    ..We reanalyzed the results from 36 unconfounded trials (i.e., addition of radiation therapy was the sole discriminant between treatments being compared) that were identified in previous meta-analyses, which provided 38 comparisons...
  5. ncbi Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
    Val Gebski
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
    Lancet Oncol 8:226-34. 2007
    ..We aimed to clarify the benefits of neoadjuvant chemoradiotherapy or chemotherapy versus surgery alone by a meta-analysis of randomised trial data...
  6. ncbi Radiotherapy in the treatment of breast cancer: a personal retrospective
    Allan O Langlands
    Breast 15:698-703. 2006
    ..The incorporation of evidence from the clinical trials in breast cancer management, changes in radiation therapy techniques and incorporation of patient choice in treatment decisions are discussed...
  7. ncbi Uterine papillary serous carcinoma: patterns of failure and survival
    Wei Wang
    Department of Radiation Oncology, Westmead Hospital, Sydney, New South Wales, Australia
    Aust N Z J Obstet Gynaecol 49:419-25. 2009
    ..To evaluate the outcome in patients with uterine papillary serous carcinoma (UPSC)...
  8. ncbi Factorial designs: a graphical aid for choosing study designs accounting for interaction
    Karen Byth
    NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia
    Clin Trials 1:315-25. 2004
    ..The method is illustrated with respect to a published 2 x 2 factorial study. In this study, interaction reduced the power of the final analysis to detect significant main effects...
  9. ncbi Dynamic balancing randomization in controlled clinical trials
    Stephane Heritier
    National Health and Medical Research Council NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
    Stat Med 24:3729-41. 2005
    ..A comparison of DBR with minimization and a biased coin design is carried out by simulation on two simulated trials...
  10. ncbi Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects?
    Anthony C Keech
    NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia
    Med J Aust 177:445-7. 2002
  11. ncbi What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation
    Silke Walleser
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, New South Wales, Australia
    Clin Gastroenterol Hepatol 5:1439-46; quiz 1368. 2007
    ..Because of high false-positive rates for FOBT, concerns have been raised about patient uptake and access to colonoscopy services. This study assessed the value of CTC as an alternative to colonoscopy in FOBT-positive individuals...
  12. ncbi Specifying objectives and outcomes for clinical trials
    Val Gebski
    NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia
    Med J Aust 176:491-2. 2002
  13. ncbi Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)
    Michaella J Smith
    NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia
    Breast Cancer Res Treat 117:99-109. 2009
    ..6). Patients' ratings on single items were 3-5 times more efficient than clinicians' measurements. Primary endpoints based on patient-rated outcome measures could reduce the required sample size in future surgical trials...
  14. ncbi Selective mastectomy in the management of locally advanced breast cancer
    Verity Ahern
    Department of Radiation Oncology, Westmead Hospital, NSW 2145, Sydney, Australia
    Int J Radiat Oncol Biol Phys 68:1010-7. 2007
    ..To evaluate local control for patients with locally advanced noninflammatory breast cancer (LABC) managed by selective mastectomy...
  15. ncbi Merkel cell carcinoma: improved outcome with adjuvant radiotherapy
    Michael J Veness
    Head and Neck Cancer Service, Westmead Hospital, Sydney, Australia
    ANZ J Surg 75:275-81. 2005
    ..Patients remain at high risk of locoregional and distant relapse despite treatment. Most studies support the incorporation of locoregional adjuvant radiotherapy in reducing the risk of relapse...
  16. ncbi Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer
    Charuwan Tantipalakorn
    Gynaecological Cancer Centre, Royal Hospital for Women and University of New South Wales, Sydney, Australia
    Obstet Gynecol 113:895-901. 2009
    ....
  17. ncbi Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice
    Michael J Veness
    Head and Neck Cancer Service, Westmead Hospital, University of Sydney, Sydney, Australia. michael.radonc.wsahs.nsw.gov.au
    Laryngoscope 115:870-5. 2005
    ..004) compared to surgery alone. CONCLUSIONS: In patients with metastatic cutaneous head and neck SCC, surgery and adjuvant radiotherapy provide the best chance of achieving locoregional control and should be considered best practice...
  18. ncbi Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy
    Margaret S-T Chua
    Joint Radiation Oncology Centre, Westmead and Nepean Hospitals, Westmead, Sydney, Australia
    Australas Radiol 46:174-9. 2002
    ..The role of altered fractionation after surgery as a means to further enhance locoregional control warrants further investigation...
  19. ncbi Secondary cytoreductive surgery for recurrent epithelial ovarian cancer
    Eng Hseon Tay
    Gynaecological Cancer Centre, Royal Hospital for Women, Department of Obstetrics and Gynaecology, University of New South Wales, Sydney, Australia
    Obstet Gynecol 99:1008-13. 2002
    ....
  20. ncbi Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment
    Michael J Veness
    Head and Neck Unit, Westmead Hospital, Sydney, New South Wales, Australia
    ANZ J Surg 73:899-904. 2003
    ..The aetiology remains unclear and the anterior tongue is a prevalent site. Prognosis has been reported as worse in young patients and some have proposed a more aggressive treatment approach...
  21. ncbi Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?
    Michael J Veness
    Head and Neck Cancer Service, Westmead Hospital, Sydney, New South Wales, Australia
    ANZ J Surg 75:101-5. 2005
    ..There is an increasing risk of cervical lymph node metastases as tumour thickness increases in patients with anterior tongue squamous cell carcinoma (SCC). The role of elective neck treatment in early anterior tongue cancer in unclear...
  22. ncbi Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck
    Michael J Veness
    Head and Neck Cancer Service, Westmead Hospital, Westmead, NSW, 2145, Sydney, Australia
    Head Neck 27:208-16. 2005
    ..The purpose of this study was to report the patterns of recurrence after initial treatment, the outcomes, and any predictors for survival...
  23. ncbi The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients
    Michael Veness
    Department of Radiation Oncology, Westmead Hospital, University of Sydney, Sydney, Australia
    Int J Radiat Oncol Biol Phys 78:703-9. 2010
    ..To review the role of radiotherapy (RTx) alone in patients with Merkel cell carcinoma (MCC)...
  24. ncbi Determining the sample size in a clinical trial
    Adrienne Kirby
    NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW
    Med J Aust 177:256-7. 2002
  25. ncbi The Chinese herbal formulation biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial
    Guorang Hu
    Department of Medicine, University of Sydney, Australia
    Ann Allergy Asthma Immunol 88:478-87. 2002
    ..Total serum immunoglobulin E was reduced after the herbal treatment. CONCLUSIONS: Our results suggest the Biminne formulation is effective in treatment of perennial AR. Its mode of action is unknown...
  26. ncbi Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer
    Andrew Kneebone
    Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Health Service, Sydney, New South Wales, Australia
    Australas Radiol 47:422-7. 2003
    ..Long-term toxicity was very acceptable. However, further improvement in outcome is desirable, and with the adoption of new technology allowing escalation of radiotherapy doses such an expectation might be achieved...
  27. ncbi Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
    Bryan H Burmeister
    University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
    Lancet Oncol 6:659-68. 2005
    ..We aimed to assess whether a short preoperative chemoradiotherapy regimen improves outcomes for patients with resectable oesophageal cancer...
  28. ncbi Randomisation in clinical trials
    Elaine M Beller
    Queensland Clinical Trials Centre, University of Queensland, Herston, QLD, Australia
    Med J Aust 177:565-7. 2002
  29. ncbi Participation in the RACS sentinel node biopsy versus axillary clearance trial
    Neil R Wetzig
    Wesley Medical Centre, Brisbane, Queensland, Australia
    ANZ J Surg 75:98-100. 2005
    ..The Royal Australasian College of Surgeons (RACS) SNAC trial is a randomized controlled trial of sentinel node biopsy (SNB) versus axillary clearance (AC). It opened in May 2001 and is recruiting rapidly with good acceptance by consumers...
  30. ncbi A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
    Michael Findlay
    Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand
    ANZ J Surg 77:247-52. 2007
    ..With poor cure rates in gastric cancer using surgery alone, the safety, efficacy and feasibility of preoperative and postoperative chemotherapy was investigated...
  31. ncbi On the issue of 'multiple' first failures in competing risks analysis
    Bee Choo Tai
    NMRC Clinical Trials and Epidemiology Research Unit, 10 College Road, Singapore 169851
    Stat Med 21:2243-55. 2002
    ..However, it takes a longer computer running time, especially when the number of replicates is large. The weighted Cox approach is the method of choice where statistical software allows its implementation without extra programming effort...
  32. ncbi Influence of the way results are presented on research interpretation and medical decision making: the PRIMER collaboration randomized studies
    Thomas Philip Shakespeare
    North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia
    Med Decis Making 28:127-37. 2008
    ..The authors evaluate whether the use of confidence levels improve research interpretation and decision making compared with P values and 95% confidence intervals...
  33. ncbi Evaluation of the quality of radiotherapy randomized trials for painful bone metastases
    Thomas P Shakespeare
    Department of Radiation Oncology, Tan Tock Seng Hospital, Singapore
    Cancer 103:1976-81. 2005
    ..The goals of the current study were to evaluate the quality of randomized studies using a validated checklist and to discuss implications and future directions...
  34. ncbi First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?
    Bee Choo Tai
    Department of Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    Stat Med 27:922-36. 2008
    ..Although the coverage is poor for a correlation of 0.7 and beyond, such a high correlation between competing event times may be biologically rather implausible...
  35. ncbi Estimating risks of radiotherapy complications as part of informed consent: the high degree of variability between radiation oncologists may be related to experience
    Thomas Philip Shakespeare
    National University Hospital, Singapore, Singapore
    Int J Radiat Oncol Biol Phys 54:647-53. 2002
    ..Estimating the risks of radiotherapy (RT) toxicity is important for informed consent; however, the consistency in estimates has not been studied. This study aimed to explore the variability and factors affecting risk estimates (REs)...
  36. ncbi Guidelines for statistical analysis of percentage of syllables stuttered data
    Mark Jones
    School of Population Health, University of Queensland, Brisbane, Australia
    J Speech Lang Hear Res 49:867-78. 2006
    ..Under these circumstances, analyses should be based on standard methods, with a suitable transformation performed prior to analysis...
  37. ncbi Patterns of metastases in familial and non-familial melanoma
    Joanne Hornbuckle
    Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, NSW 2145, Australia
    Melanoma Res 13:105-9. 2003
    ..Genetic susceptibility for melanoma may lower the threshold for entering an otherwise common molecular pathway for tumour development and evolution...
  38. ncbi A randomized trial evaluating rigid immobilization for pelvic irradiation
    Andrew Kneebone
    Cancer Therapy Centre, Liverpool Hospital, Liverpool, Australia
    Int J Radiat Oncol Biol Phys 56:1105-11. 2003
    ..In recent years, a number of pelvic immobilization techniques have been developed. Few have been evaluated in randomized trials, and many of these studies have produced contradictory and inconclusive results...
  39. ncbi Presenting symptoms of epithelial ovarian cancer
    Isam Lataifeh
    Gynaecological Cancer Centre, Royal Hospital for Women, University of New South Wales, Australia
    Aust N Z J Obstet Gynaecol 45:211-4. 2005
    ..CONCLUSION: Patients with early stage ovarian cancer are likely to be younger and to have larger, better differentiated tumours that are more often non-serous histologically. Advanced disease is not invariably due to delayed diagnosis...
  40. ncbi Statistical power in stuttering research: a tutorial
    Mark Jones
    National Health and Medical Research Council of Australia, Clinical Trials Centre, The University of Sydney
    J Speech Lang Hear Res 45:243-55. 2002
    ..With this in mind, the paper concludes with an attempt to open discussion about ways to redress the problems associated with statistical power...